Accuitis Inc.
Biotechnology company · Alpharetta, Georgia, United States
Accuitis Inc. is a biotechnology company headquartered in Alpharetta, Georgia, United States. Its earliest recorded incorporation is in 2011. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2018.
Accuitis at a glance
What does Accuitis do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $1 million sold (2018).
Frequently asked questions about Accuitis
Where is Accuitis headquartered?
Accuitis Inc. is headquartered in Alpharetta, Georgia, United States.
What does Accuitis do?
Accuitis Inc. is a biotechnology company.
When was Accuitis founded?
The earliest incorporation on record for Accuitis Inc. is in 2011, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences